Correlation Between Milestone Pharmaceuticals and Adagene
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Adagene, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Adagene.
Diversification Opportunities for Milestone Pharmaceuticals and Adagene
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Milestone and Adagene is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Adagene go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Adagene
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Adagene. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Pharmaceuticals is 1.39 times less risky than Adagene. The stock trades about -0.02 of its potential returns per unit of risk. The Adagene is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 187.00 in Adagene on August 27, 2024 and sell it today you would earn a total of 32.00 from holding Adagene or generate 17.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Adagene
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Adagene |
Milestone Pharmaceuticals and Adagene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Adagene
The main advantage of trading using opposite Milestone Pharmaceuticals and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.The idea behind Milestone Pharmaceuticals and Adagene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Adagene vs. Eliem Therapeutics | Adagene vs. HCW Biologics | Adagene vs. Scpharmaceuticals | Adagene vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |